These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 3087615)
1. Enhancement of beta-propiolactone tumorigenesis in mouse skin by pretreatment with the anti-inflammatory steroid fluocinolone acetonide. Woodworth BA; Scribner JD; Scribner NK Cancer Lett; 1986 Jun; 31(3):293-7. PubMed ID: 3087615 [TBL] [Abstract][Full Text] [Related]
2. Inhibition of phorbol ester-induced tumor promotion in mice by vitamin A analog and anti-inflammatory steroid. Weeks CE; Slaga TJ; Hennings H; Gleason GL; Bracken WM J Natl Cancer Inst; 1979 Aug; 63(2):401-6. PubMed ID: 110970 [TBL] [Abstract][Full Text] [Related]
3. Lack of effect of retinoic acid and fluocinolone acetonide on mirex tumor promotion indicates a novel mirex mechanism. Kim TW; Smart RC Carcinogenesis; 1995 Sep; 16(9):2199-204. PubMed ID: 7554075 [TBL] [Abstract][Full Text] [Related]
4. Phorbol myristate acetate and catechol as skin cocarcinogens in SENCAR mice. Van Duuren BL; Melchionne S; Seidman I Environ Health Perspect; 1986 Sep; 68():33-8. PubMed ID: 3780629 [TBL] [Abstract][Full Text] [Related]
5. Inhibition of beta-propiolactone-induced neoplasia of the forestomach and large bowel by 4-mercaptobenzene sulfonate in mice and rats. Hochalter JB; Wattenberg LW; Coccia JB; Galbraith AR Cancer Res; 1988 May; 48(10):2740-3. PubMed ID: 3359434 [TBL] [Abstract][Full Text] [Related]
6. Promotion of mouse two-stage skin carcinogenesis by diacylglycerol-rich edible oil. Takasuka N; Takahashi M; Hori Y; Kitahashi T; Iigo M; Imai T; Yoshimi N; Sugimura T; Wakabayashi K Cancer Lett; 2009 Mar; 275(1):150-7. PubMed ID: 19028010 [TBL] [Abstract][Full Text] [Related]
7. Tumor initiating activity of 9- and 10-fluoro-7,12-dimethylbenz[a]-anthracene (DMBA) and the effect of 2,3,7,8-tetrachlorodibenzo-p-dioxin on tumor initiation by monofluoro derivatives of DMBA in SENCAR mice. DiGiovanni J; Decina PC; Diamond L Carcinogenesis; 1983 Aug; 4(8):1045-9. PubMed ID: 6409443 [TBL] [Abstract][Full Text] [Related]
8. Altered glucocorticoid receptor expression and function during mouse skin carcinogenesis. Budunova IV; Carbajal S; Kang H; Viaje A; Slaga TJ Mol Carcinog; 1997 Mar; 18(3):177-85. PubMed ID: 9115588 [TBL] [Abstract][Full Text] [Related]
9. SENCAR mouse skin tumorigenesis model versus other strains and stocks of mice. Slaga TJ Environ Health Perspect; 1986 Sep; 68():27-32. PubMed ID: 3096709 [TBL] [Abstract][Full Text] [Related]
10. A course of very small doses of DMBA, each of them allegedly with no promoting potency, acts with clear synergistic effect as a strong promoter of DMBA-initiated mouse skin carcinogenesis. A comparison of the tumorigenic and carcinogenic effects of DMBA (7,12-dimethylbenz-alpha-anthracene) and TPA (12-O-tetradecanoyl-phorbol-13-acetate) used as initiators and promoters in classical two-stage experimental protocols. Iversen OH APMIS Suppl; 1994; 41():1-38. PubMed ID: 7946481 [TBL] [Abstract][Full Text] [Related]
11. Induction of in vitro transformation by near-u.v. light and its interaction with beta-propiolactone. Baturay NZ; Targovnik HS; Reynolds RJ; Kennedy AR Carcinogenesis; 1985 Mar; 6(3):465-8. PubMed ID: 3978759 [TBL] [Abstract][Full Text] [Related]
12. Tumorigenesis and carcinogenesis studies of a number of insulation oils and fluids on hairless and SENCAR mice with special reference to skin tumours and malignant lymphomas. Iversen OH APMIS Suppl; 1990; 13():1-60. PubMed ID: 2357397 [TBL] [Abstract][Full Text] [Related]
13. Isoflavone genistein inhibits the initiation and promotion of two-stage skin carcinogenesis in mice. Wei H; Bowen R; Zhang X; Lebwohl M Carcinogenesis; 1998 Aug; 19(8):1509-14. PubMed ID: 9744550 [TBL] [Abstract][Full Text] [Related]
14. Evidence for a new model of tumor progression from carcinogenesis and tumor promotion studies with 7-bromomethylbenz[a]anthracene. Scribner JD; Scribner NK; McKnight B; Mottet NK Cancer Res; 1983 May; 43(5):2034-41. PubMed ID: 6403231 [TBL] [Abstract][Full Text] [Related]
15. Studies on mechanism of action of anti-tumor-promoting agents: their specificity in two-stage promotion. Slaga TJ; Klein-Szanto AJ; Fischer SM; Weeks CE; Nelson K; Major S Proc Natl Acad Sci U S A; 1980 Apr; 77(4):2251-4. PubMed ID: 6769125 [TBL] [Abstract][Full Text] [Related]
16. Differential carcinogenic effects of intraperitoneal initiation with 7,12-dimethylbenz(a)anthracene or urethane and topical promotion with 12-O-tetradecanoylphorbol-13-acetate in skin and internal tissues of female SENCAR and BALB/c mice. Ward JM; Rehm S; Devor D; Hennings H; Wenk ML Environ Health Perspect; 1986 Sep; 68():61-8. PubMed ID: 3096710 [TBL] [Abstract][Full Text] [Related]
17. Comparative dose-response tumorigenicity studies of dibenzo[alpha,l]pyrene versus 7,12-dimethylbenz[alpha]anthracene, benzo[alpha]pyrene and two dibenzo[alpha,l]pyrene dihydrodiols in mouse skin and rat mammary gland. Cavalieri EL; Higginbotham S; RamaKrishna NV; Devanesan PD; Todorovic R; Rogan EG; Salmasi S Carcinogenesis; 1991 Oct; 12(10):1939-44. PubMed ID: 1934274 [TBL] [Abstract][Full Text] [Related]
18. Interleukin-1alpha up-regulation in vivo by a potent carcinogen 7,12-dimethylbenz(a)anthracene (DMBA) and control of DMBA-induced inflammatory responses. Li X; Eckard J; Shah R; Malluck C; Frenkel K Cancer Res; 2002 Jan; 62(2):417-23. PubMed ID: 11809690 [TBL] [Abstract][Full Text] [Related]
19. Tumor-initiating activity of 4-fluoro-7,12-dimethylbenz[a]anthracene and 1,2,3,4-tetrahydro-7,12-dimethylbenz[a]anthracene in female SENCAR mice. DiGiovanni J; Diamond L; Singer JM; Daniel FB; Witiak DT; Slaga TJ Carcinogenesis; 1982; 3(6):651-5. PubMed ID: 6811143 [TBL] [Abstract][Full Text] [Related]
20. Skin tumorigenesis and carcinogenesis studies with 7,12-dimethylbenz[a]anthracene, ultraviolet light, benzoyl peroxide (Panoxyl gel 5%) and ointment gel. Iversen OH Carcinogenesis; 1988 May; 9(5):803-9. PubMed ID: 3130205 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]